via University of Queensland
University of Queensland researchers said the ability to provide two functions in one cell meant the cells could be used to regenerate or repair cell and tissue damage across a number of areas in the body.
This also means that arteries and veins could be created an engineer tissue to provide more effective treatments for a range of musculoskeletal and degenerative disorders including pulmonary fibrosis and heart disease.
This regenerative process is key to taking the next step in stem cell treatment.
For more details: Two in one: human placenta stem cells hold a dual benefit
The Latest on: Stem cell treatment
via Google News
The Latest on: Stem cell treatment
- Designer DNA molecule helps hunt down cancer stem cells in bloodon January 20, 2021 at 10:03 pm
Like weeds that grow back if you don’t remove the roots, cancer can keep returning thanks to lurking stem cells. Now, researchers have developed a “designer” DNA segment that can eradicate these ...
- Hematopoietic stem cell transplants may prevent worsening of MS disabilityon January 20, 2021 at 5:54 pm
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people ...
- Hematopoietic stem cell transplants may provide long-term benefit for people with MSon January 20, 2021 at 2:43 pm
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people ...
- AKU wins Rs14.5m HEC grant to develop stem-cell treatmentson January 20, 2021 at 2:24 pm
The Centre for Regenerative Medicine and Stem Cell Research (CRM) of Aga Khan University (AKU) has won a Rs14.5 million grant to develop new, targeted therapies for a common form of blood cancer in ...
- Hematopoietic stem cell transplants may provide long-term benefit for people with multiple sclerosison January 20, 2021 at 1:03 pm
A new study shows that intense immunosuppression followed by a hematopoietic stem cell transplant may prevent disability associated with multiple sclerosis (MS) from getting worse in 71% of people ...
- Designer DNA agent reduces myeloma stem cell abundance, lowers disease burden in miceon January 20, 2021 at 11:54 am
Many patients with multiple myeloma, a type of blood cancer, eventually develop resistance to one treatment after another. That's in part because cancer stem cells drive the disease -- cells that ...
- Designer DNA therapeutic wipes out cancer stem cells, treats multiple myeloma in miceon January 20, 2021 at 10:13 am
A new study supports launch of Phase I clinical trial to test a designer DNA agent -- an antisense oligonucleotide that targets a gene called IRF4 -- in patients with multiple myeloma.
- Chinese scientists develop gene therapy that could delay agingon January 20, 2021 at 10:13 am
Scientists in Beijing have developed a new gene therapy which can reverse some of the effects of aging in mice and extend their lifespans, findings which may one day contribute to ...
- Interventional Orthopedics Connecticut Provide An Expert Opinion: 7 TRUTHS About Stem Cell Therapyon January 20, 2021 at 6:58 am
Dr Southern explaining stem cell therapy injection to a patient With the amount of information out there about stem cell therapy, it can be difficult to find the truth. Dr. Daniel Southern ...
- Stem Cells Market to Reach USD 17.78 Billion | Global Size Analysis, Segmentation, Industry Outlook, and Forecasts 2021-2027on January 20, 2021 at 3:37 am
Increasing occurrence of diseases and surging adoption of stem cell therapies are fueling the market growth. Market size: USD 9.35 billion in 2019 Market ...
via Bing News
